Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
100% from low
Exchange
OTC Link
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Revenue | $72.2K | $65.1K | $488.7K |
| Cost of revenue | $70.2K | $64.0K | $456.9K |
| Gross profit | $2.0K | $1.1K | $31.8K |
| Gross margin | 2.8% | 1.7% | 6.5% |
| R&D | $0 | $0 | $0 |
| Operating income | −$750 | −$590 | −$2.2M |
| EBITDA | $171.1K | −$590 | −$2.2M |
| Net income | −$750 | −$512 | −$2.2M |
| Net margin | -1.0% | -0.8% | -457.9% |
| EPS (diluted) | 0.00 | 0.00 | -0.01 |
Annual figures · source: Financial Modeling Prep
EVER HARVEST INTL GRP
No one on the platform currently holds TLGN.
No tracked institution reports a position in TLGN as of their last filing.
| Execution date | Ratio |
|---|---|
| 2012-09-07 | 1-for-100reverse |
No one on the platform has traded TLGN yet.
| +0.00% |
| $576 |
| — |
| CIVXCTR Investments & Consulting, Inc. | $0.00 | -50.00% | $14007 | — |
| IMMGImmage Biotherapeutics Corp. | $0.00 | +0.00% | $15174 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.